【结 构 式】 ![]() |
【分子编号】59267 【品名】N-methyl-N-(4-phenyl-4-piperidinyl)acetamide 【CA登记号】 |
【 分 子 式 】C14H20N2O 【 分 子 量 】232.32568 【元素组成】C 72.38% H 8.68% N 12.06% O 6.89% |
合成路线1
该中间体在本合成路线中的序号:(X)N-Benzyl-4-hydroxy-4-phenylpiperidine (II) was prepared by addition of phenyllithium to N-benzyl-4-piperidone (I). Carbinol (II) was then converted to acetamide (III) by acid-catalyzed Ritter reaction with acetonitrile. Replacement of the acetamido for an N-Boc group in (III) was effected by acidic hydrolysis of amide (III) to give (IV), followed by treatment with di-tert-butyl dicarbonate. The resultant 1-benzyl-4-(Boc-amino)-4-phenylpiperidine (V) was subjected to catalytic hydrogenolysis in the presence of Pd/C, and the N-debenzylated piperidine (VI) was reprotected as the N-trityl derivative (VII) by treatment with triphenylmethyl chloride and triethylamine. Reduction of the N-Boc group of (VII) by LiAlH4, yielded the N-methyl amine (VIII). After acylation of (VIII) with acetyl chloride to acetamide (IX), its N-trityl group was cleaved by treatment with hot aqueous formic acid to produce the intermediate piperidine (X).
【1】 Bichon, D.; Van Broeck, D.; Proietto, V.; Gueule, P.; Emonds-Alt, X. (Sanofi-Synthélabo); Novel N-(3,4-dichlorophenyl-propyl)-piperidine derivs. as selective human NK3-receptor antagonists. EP 0673928; FR 2717477; FR 2717478; FR 2719311; JP 1996048669; US 5741910; US 5942523; US 6124316 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 15720 | 1-benzyltetrahydro-4(1H)-pyridinone; 1-Benzyl-4-piperidone; N-Benzyl-4-piperidone; 1-(benzyl)-4-piperidinone; 1-benzylpiperidin-4-one; 1-(benzyl)piperidin-4-one | 3612-20-2 | C12H15NO | 详情 | 详情 |
(II) | 29470 | 1-benzyl-4-phenyl-4-piperidinol | C18H21NO | 详情 | 详情 | |
(III) | 54993 | N-(1-benzyl-4-phenyl-4-piperidinyl)acetamide | C20H24N2O | 详情 | 详情 | |
(IV) | 54994 | 1-benzyl-4-phenyl-4-piperidinylamine; 1-benzyl-4-phenyl-4-piperidinamine | C18H22N2 | 详情 | 详情 | |
(V) | 59263 | tert-butyl 1-benzyl-4-phenyl-4-piperidinylcarbamate | C23H30N2O2 | 详情 | 详情 | |
(VI) | 54998 | tert-butyl 4-phenyl-4-piperidinylcarbamate | C16H24N2O2 | 详情 | 详情 | |
(VII) | 59264 | tert-butyl 4-phenyl-1-trityl-4-piperidinylcarbamate | C35H38N2O2 | 详情 | 详情 | |
(VIII) | 59265 | N-methyl-4-phenyl-1-trityl-4-piperidinamine; N-methyl-N-(4-phenyl-1-trityl-4-piperidinyl)amine | C31H32N2 | 详情 | 详情 | |
(IX) | 59266 | N-methyl-N-(4-phenyl-1-trityl-4-piperidinyl)acetamide | C33H34N2O | 详情 | 详情 | |
(X) | 59267 | N-methyl-N-(4-phenyl-4-piperidinyl)acetamide | C14H20N2O | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(X)Michael addition of methyl acrylate (XII) to (3,4-dichlorophenyl)acetonitrile (XI) produced the cyano diester adduct (XIII). Catalytic hydrogenation of the cyano group of (XIII) over Raney nickel with concomitant intramolecular cyclization gave rise to the piperidinone (XIV). After basic hydrolysis of the methyl ester function of (XIV), the resultant piperidone propionic acid (XV) was reduced to piperidino alcohol (XVI) by means of borane in THF. Resolution of the racemic piperidine (XVI) employing (+)-camphorsulfonic acid provided the dextro enantiomer (XVII). After N-protection of (XVII) as the Boc derivative (XVIII), its primary alcohol was activated as the corresponding mesylate (XIX) with methanesulfonyl chloride and Et3N. Condensation between mesylate (XIX) and intermediate piperidine (X) in acetonitrile at 60 C, produced (XX). The title benzamido derivative was then obtained by acid-promoted Boc group cleavage in (XX), followed by acylation with benzoyl chloride.
【1】 Bichon, D.; Van Broeck, D.; Proietto, V.; Gueule, P.; Emonds-Alt, X. (Sanofi-Synthélabo); Novel N-(3,4-dichlorophenyl-propyl)-piperidine derivs. as selective human NK3-receptor antagonists. EP 0673928; FR 2717477; FR 2717478; FR 2719311; JP 1996048669; US 5741910; US 5942523; US 6124316 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(X) | 59267 | N-methyl-N-(4-phenyl-4-piperidinyl)acetamide | C14H20N2O | 详情 | 详情 | |
(XI) | 26935 | 2-(3,4-dichlorophenyl)acetonitrile | 3218-49-3 | C8H5Cl2N | 详情 | 详情 |
(XII) | 14156 | methyl acrylate | 96-33-3 | C4H6O2 | 详情 | 详情 |
(XIII) | 59268 | dimethyl 4-cyano-4-(3,4-dichlorophenyl)heptanedioate | C16H17Cl2NO4 | 详情 | 详情 | |
(XIV) | 59269 | methyl 3-[3-(3,4-dichlorophenyl)-6-oxo-3-piperidinyl]propanoate | C15H17Cl2NO3 | 详情 | 详情 | |
(XV) | 59270 | 3-[3-(3,4-dichlorophenyl)-6-oxo-3-piperidinyl]propanoic acid | C14H15Cl2NO3 | 详情 | 详情 | |
(XVI) | 29465 | 3-[3-(3,4-dichlorophenyl)-3-piperidinyl]-1-propanol | C14H19Cl2NO | 详情 | 详情 | |
(XVII) | 29466 | 3-[(3S)-3-(3,4-dichlorophenyl)piperidinyl]-1-propanol | C14H19Cl2NO | 详情 | 详情 | |
(XVIII) | 59271 | tert-butyl (3S)-3-(3,4-dichlorophenyl)-3-(3-hydroxypropyl)-1-piperidinecarboxylate | C19H27Cl2NO3 | 详情 | 详情 | |
(XIX) | 59272 | tert-butyl (3S)-3-(3,4-dichlorophenyl)-3-{3-[(methylsulfonyl)oxy]propyl}-1-piperidinecarboxylate | C20H29Cl2NO5S | 详情 | 详情 | |
(XX) | 59273 | tert-butyl (3R)-3-(3-{4-[acetyl(methyl)amino]-4-phenyl-1-piperidinyl}propyl)-3-(3,4-dichlorophenyl)-1-piperidinecarboxylate | C33H45Cl2N3O3 | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(XXXIX)An alternative preparation of the precursor 4-(N-methyl-N-acetyl)amino-4-phenylpiperidine (XXXIX) has been reported. The N-benzyl protecting group of piperidine (III) was replaced with an N-Boc group by catalytic hydrogenolysis to (XXXVI), followed by treatment with Boc2O to yield (XXXVII). Amide (XXXVII) alkylation with iodomethane under phase-transfer conditions gave the N-methyl derivative (XXXVIII). Subsequent N-Boc group cleavage in (XXXVIII) was accomplished by using zinc chloride in CH2Cl2 to afford the piperidine-ZnCl2 complex (XXXIX). This was then alkylated with mesylate (XXVII), and the title compound was finally isolated from the racemic mixture by means of preparative chiral HPLC.
【1】 Giardina, G.A.M.; et al.; A reliable and efficient synthesis of SR 142801. Bioorg Med Chem Lett 1996, 6, 19, 2307. |
【2】 Grugni, M.; Rigolio, R.; Erhard, K.F. (GlaxoSmithKline Inc.; GlaxoSmithKline SpA); Process for the preparation of 3,3-disubstd. piperidines. WO 9805640 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(III) | 54993 | N-(1-benzyl-4-phenyl-4-piperidinyl)acetamide | C20H24N2O | 详情 | 详情 | |
(XXVII) | 59278 | 3-[1-benzoyl-3-(3,4-dichlorophenyl)-3-piperidinyl]propyl methanesulfonate | C22H25Cl2NO4S | 详情 | 详情 | |
(XXXVI) | 59283 | N-(4-phenyl-4-piperidinyl)acetamide | C13H18N2O | 详情 | 详情 | |
(XXXVII) | 59284 | tert-butyl 4-(acetylamino)-4-phenyl-1-piperidinecarboxylate | C18H26N2O3 | 详情 | 详情 | |
(XXXVIII) | 59285 | tert-butyl 4-[acetyl(methyl)amino]-4-phenyl-1-piperidinecarboxylate | C19H28N2O3 | 详情 | 详情 | |
(XXXIX) | 59267 | N-methyl-N-(4-phenyl-4-piperidinyl)acetamide | C14H20N2O | 详情 | 详情 |
合成路线4
该中间体在本合成路线中的序号:(X)A new method has been reported. Formamide (XL) was prepared form carbinol (II) by a modified Ritter reaction with cyanotrimethylsilane. Subsequent reduction of (XL) with LiAlH4 gave the N-methyl amine (XLI), which was converted to acetamide (XLIV) by treatment with acetyl chloride. Benzyl group hydrogenolysis in (XLIV) afforded the piperidine (X). Finally, alkylation of piperidine (X) with the chiral alkyl iodide (XXXV) provided the title compound.
【1】 Chen, H.G.; et al.; A practical and scalable synthesis of SR 142801, a tachykinin NK3 antagonist. Bioorg Med Chem Lett 1997, 7, 5, 555. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(II) | 29470 | 1-benzyl-4-phenyl-4-piperidinol | C18H21NO | 详情 | 详情 | |
(X) | 59267 | N-methyl-N-(4-phenyl-4-piperidinyl)acetamide | C14H20N2O | 详情 | 详情 | |
(XXXV) | 29469 | [(3S)-3-(3,4-dichlorophenyl)-3-(3-iodopropyl)piperidinyl](phenyl)methanone | C21H22Cl2INO | 详情 | 详情 | |
(XL) | 59286 | 1-benzyl-4-phenyl-4-piperidinylformamide | C19H22N2O | 详情 | 详情 | |
(XLI) | 59287 | 1-benzyl-N-methyl-4-phenyl-4-piperidinamine; N-(1-benzyl-4-phenyl-4-piperidinyl)-N-methylamine | C19H24N2 | 详情 | 详情 | |
(XLIV) | 59290 | N-(1-benzyl-4-phenyl-4-piperidinyl)-N-methylacetamide | C21H26N2O | 详情 | 详情 |